根据实践意义,在哈萨克斯坦优先考虑临床试验开发的算法转换
Talgat Nurgozhin1, Gulnara Kulkayeva1, Margarita Graf1
1Salidat Kairbekova National Research Center for Health Development of the Ministry of Health of the Republic of Kazakhstan, Astana, Republic of Kazakhstan.
The International journal of health planning and management
|January 10, 2025
概括
评估临床试验对于医疗保健资源分配至关重要. 这项研究发现,许多项目缺乏实用性,团队支持和公众需求,需要改进评估系统以获得更好的医学研究成果.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 医学研究评估 医学研究评估
- 赠款资金管理 赠款资金管理
背景情况:
- 医疗保健资源有限,需要有效地分配和实践应用研究成果.
- 提高医疗护理质量需要将科学研究成果纳入实践.
- 需要一个强大的临床试验评估系统来优先考虑有影响力的医疗保健研究.
研究的目的:
- 确定评估临床试验的关键标准.
- 开发一个系统来评估医学研究的实际适用性.
- 优先考虑对医疗保健影响最大潜力的研究领域.
主要方法:
- 对17个政府资助的临床医学研究项目的专家评估.
- 使用一个多标准评估系统,有4个类别和大约20个指标.
- 37名专家参与了评估过程.
主要成果:
- 超过58%的项目需要改变团队组成;70%需要外部方法支持.
- 不到一半 (47.1%) 解决了国家卫生问题;23.5%的公共需求较低.
- 显著的挑战包括时间框架不足 (专门项目的76.5%) 和评估经济效率的困难 (17.2%).
结论:
- 目前临床试验评估流程需要改进,以提高实际意义.
- 提供了优化医学研究评估和资助资助效率的建议.
- 制定标准化的评估方法可以带来更有影响力的医疗保健研究.
相关概念视频
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
119
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
119
Primary Healthcare Services
1.3K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.3K
Hazard Ratio
85
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
85


